Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Alzheimer's disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement

Doulberis M, Kotronis G, Gialamprinou D, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J.

Int J Neurosci. 2021 Mar;131(3):289-301. doi: 10.1080/00207454.2020.1738432. Epub 2020 Mar 13.

Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study

Darbà J, Marsà A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1101-1106. doi: 10.1080/14737167.2020.1820328. Epub 2020 Sep 14.

Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review

Thunell J, Chen Y, Joyce G, Barthold D, Shekelle PG, Brinton RD, Zissimopoulos J.

Alzheimers Dement. 2021 Jan;17(1):41-48. doi: 10.1002/alz.12175. Epub 2020 Oct 8.

[Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies]

Defrancesco M, Bancher C, Dal-Bianco P, Hinterhuber H, Schmidt R, Struhal W, Ransmayr G, Stögmann E, Marksteiner J.

Neuropsychiatr. 2021 Mar;35(1):35-47. doi: 10.1007/s40211-020-00363-9. Epub 2020 Oct 29.

Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes

Llibre-Guerra JJ, Li Y, Allegri RF, Mendez PC, Surace EI, Llibre-Rodriguez JJ, Sosa AL, Aláez-Verson C, Longoria EM, Tellez A, Carrillo-Sánchez K, Flores-Lagunes LL, Sánchez V, Takada LT, Nitrini R, Ferreira-Frota NA, Benevides-Lima J, Lopera F, Ramírez L, Jiménez-Velázquez I, Schenk C, Acosta D, Behrens MI, Doering M, Ziegemeier E, Morris JC, McDade E, Bateman RJ.

Alzheimers Dement. 2021 Apr;17(4):653-664. doi: 10.1002/alz.12227. Epub 2020 Nov 23.

Late-Life Depression and Alzheimer's Disease Pathology: An Ounce of Prevention, a Pound of Cure

Gatchel JR.

Am J Geriatr Psychiatry. 2021 May;29(5):458-461. doi: 10.1016/j.jagp.2020.11.006. Epub 2020 Nov 28.

Diabetes-Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance

Carvalho C, Cardoso S.

Antioxid Redox Signal. 2021 Mar 10;34(8):631-649. doi: 10.1089/ars.2020.8056. Epub 2020 Apr 20.

Different Methods to Assess the Nutritional Status of Alzheimer Patients

Martínez-Tomé M, Murcia MA, Rosario C, Mariscal-Arcas M, Jiménez-Monreal AM.

J Am Coll Nutr. 2021 Jan;40(1):86-93. doi: 10.1080/07315724.2020.1737594. Epub 2020 Mar 26.

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S; Alzheimer Precision Medicine Initiative.

Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.

Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate

van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.

Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments

Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.

Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.

Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and (1)H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review

Piersson AD, Mohamad M, Rajab F, Suppiah S.

Acad Radiol. 2021 Oct;28(10):1447-1463. doi: 10.1016/j.acra.2020.06.006. Epub 2020 Jul 7.

Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients

Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.

Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.

The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease

Lau HHC, Ingelsson M, Watts JC.

Acta Neuropathol. 2021 Jul;142(1):17-39. doi: 10.1007/s00401-020-02201-2. Epub 2020 Aug 2.

Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials

Gleason A, Ayton S, Bush AI.

Eur J Neurol. 2021 Jan;28(1):e1. doi: 10.1111/ene.14484. Epub 2020 Sep 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias